Clinical Trials Browser

Rhabdomyosarcoma × atezolizumab × 1 year × Clear all

NCT04796012 2026-06-02

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

Phase 1/2 Recruiting

Rhabdomyosarcoma